Infectious Diseases /

Red Book: 2024 Report of the Committee on Infectious Diseases, 33rd Edition [Paperback]

Name: Red Book: 2024 Report of the Committee on Infectious Diseases, 33rd Edition [Paperback]
Brand: American Academy of Pediatrics
SKU: 224C6BA9-6E05-4FA6-AFDE-6DF7B9E956B3

Editor: David W. Kimberlin, MD, FAAP; Associate Editors: Ritu Banerjee, MD, PhD, FAAP, Elizabeth D. Barnett, MD, FAAP; Ruth Lynfield, MD, FAAP; Mark H. Sawyer, MD, FAAP

AAP Members - Click here to request a print copy of Red Book 2024 as your member beneﬁt!

Format

Price: $175.00

Member Price: $140.00

Quantity

The amount must be greater than 0

Product Information

Description

For more than 85 years, health care professionals have “referred to the Red Book” for trustworthy guidance on pediatric infectious disease prevention, management, and control.

The new 33rd edition continues this tradition of distinction with the latest clinical guidance on the manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood infectious diseases.

Find the latest information about vaccines, emerging novel diseases, diagnostic modalities, and treatment recommendations from the combined expertise of the CDC, the FDA, the NIH, and hundreds of physician contributors.

Red Book guidance spans far beyond the pediatric practice to include family medicine, emergency medicine, public health, school health, and other medical specialties.

New in the 2024 Red Book

All chapters were assessed for relevance in the dynamic environment that is the practice of pediatric medicine today, and every chapter has been modified since the last edition.
Significantly revised Discussing Vaccines With Patients and Parents chapter
Two new chapters on COVID-19 and Mpox have been added
Greatly expanded tables, figures and algorithms enable quick access to essential information
The System-Based Treatment Table has been reordered so that the grouped recommendations by body system are more easily and quickly accessed.
Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout the Red Book.
Reference to evidence-based policy recommendations have been updated throughout the Red Book.
Appropriate chapters throughout the Red Book have been updated to be consistent with 2024 AAP and CDC vaccine recommendations, CDC recommendations for immunization of health care personnel, and drug recommendations from 2024 Nelson’s Pediatric Antimicrobial Therapy.
The Breastfeeding and Human Milk chapter was updated to align with information in the 2022 AAP policy statement on breastfeeding.
The listing of Codes for Commonly Administered Pediatric Vaccines, Toxoids, and Immune Globulins has been expanded.

Buy more and save!
10-24 copies Save 10% Member Price: $126 Price: $157.50
25-99 copies Save 20% Member Price: $112 Price: $140.00
100-249 copies Save 25% Member Price: $105 Price: $131.25
250-499 copies Save 30% Member Price: $98 Price: $122.50
500-999 copies Save 40% Member Price: $84 Price: $105.00
1000+ copies - Contact nationalaccounts@aap.org or call 800/433-9016 ext. 6091

Details

ISBN-13: 978-1-61002-734-2
Product Code: MA1140
Publication Date: May 15, 2024
Format: Paperback
Pages: 1261
Availability: In Stock

About the Authors

Editor

David W. Kimberlin, MD, FAAP

David W. Kimberlin, MD, FAAP is the Editor of the 2024 and 2021 editions of AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 and 2018 editions and was an Associate Editor of the 2012 and 2009 editions and served on the AAP Committee on Infectious Diseases from 2005- 2011.

Dr Kimberlin is the Sergio Stagno, MD. Endowed Chair in Infectious Diseases, Professor and Co-Division Director, Vice Chair for Clinical and Translational Research.

His clinical and research interests include pediatric infectious diseases, antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome.

Associate Editor

Ritu Banerjee, MD, PhD, FAAP

Dr. Ritu Banerjee is Professor in the Division of Pediatric Infectious Diseases at Vanderbilt University Medical Center. She is the Director of the Pediatric Antimicrobial Stewardship Program and Interim Director of Pediatric Infectious Diseases at Vanderbilt. She received her MD and Ph.D degrees from Washington University in St. Louis and then completed Pediatrics residency and Pediatric Infectious Disease fellowship at the University of California, San Francisco.She is a member of many national committees through the Pediatric Infectious Diseases Society, the American Academy of Pediatrics, the Infectious Diseases Society of America, and the Antibacterial Resistance Leadership Group. Dr. Banerjee conducts clinical research about antibiotic stewardship, implementation and outcomes of rapid blood culture diagnostics, and enhanced detection of carbapenem-resistant organisms.

Associate Editor

Elizabeth Barnett, MD

Elizabeth D. Barnett, MD, FAAP is an Associate Editor of the 2024 and 2021 editions of Red Book and was a member on the Committee on Infectious Diseases from 2014-2020. Dr Elizabeth Barnett is Professor of Pediatrics at Boston University School of Medicine and Chief, Section of Pediatric Infectious Diseases in the Department of Pediatrics at Boston Medical Center. She leads the Refugee Health Assessment Program and the Pediatric Travel Clinic. Her clinical and research interests include vaccines and vaccine safety, refugee and immigrant medicine, travel medicine, and general pediatric infectious diseases.

Associate Editor

Ruth Lynfield, MD, FAAP

Ruth Lynfield, MD, FAAP is an Associate Editor of the 2024 and 2021 editions of Red Book and has been a member of the the Committee on Infectious Diseases since 2015. Dr Lynfield is the State Epidemiologist and Medical Director at the Minnesota Department of Health. She leads Minnesota’s component of CDC’s Emerging Infections Program Active Bacterial Core Surveillance System, influenza projects, and healthcare-associated infections projects. She is also Adjunct Professor of Medicine, and Epidemiology and Community Health at the University of Minnesota. Her clinical and research interests include pediatric infectious diseases, antimicrobial resistance and antimicrobial stewardship, emerging infections, prevention and control of infectious diseases, and outbreak response.

Associate Editor

Mark H. Sawyer, MD, FAAP

Mark Sawyer, MD, FAAP is an Associate Editor of the 2024 and 2021 editions of Red Book and served on the Committee on Infectious Diseases from 2013- 2019. Dr. Sawyer is an infectious disease specialist at Rady Children's Hospital and a professor of clinical pediatrics at UC San Diego. Additionally, Dr Sawyer is vice chair for education in the UC San Diego Department of Pediatrics and the program director for the UC San Diego/Rady Children's Pediatric Residency Program and the medical director of the UC San Diego Immunization Partnership. His clinical and research interests include pediatric infectious diseases, medical education, training, and working with public health on the delivery of vaccines and national vaccine policy.